Abstract 1508: Characterization of a novel clonal neoantigen reactive T cell (cNeT) product through a comprehensive translational research program
Michael Epstein(Granta Design (United Kingdom)), Sergio A. Quezada(Memorial Sloan Kettering Cancer Center), M. Förster, Megan Wileman, Daisy Melandri, Natasa Hadjistephanou(University of Wolverhampton), Mariam Jamal‐Hanjani(CRUK Lung Cancer Centre of Excellence), Iraj Ali, Leah Manning, Amy L. Baker, Samra Turaljic(The Francis Crick Institute), Rebecca Pike, Jen Middleton, Pablo D. Becker(United Therapeutics (United Kingdom)), Emma Leire, Theres Oakes(University College London), Eva Pekle, Jane Robertson(Cancer Research UK), Karl S. Peggs(Royal London Hospital), Anabel Ramírez, Mark Brown, Lylia Ouboussad
Cited by 2
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k